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Introduction 
Superior mesenteric vein thrombosis (SMVT) is a rare condition that causes intestinal 
ischemia, and can be quite difficult to diagnose. SMVT diagnoses have increased in the 
last two decades, probably due to the increased use and availability of contrast-enhanced 
computed tomography (CT) scans for diagnosing patients with portal hypertension or 
abdominal pain. SMVT frequently occurs in young adults, and may be caused by infection 
(e.g. cytomegalovirus in immunocompetent patients) 
1
, intra-abdominal inflammatory 
diseases (acute cholecystitis, pancreatitis or appendicitis) 
2
, portal hypertension, splenec-
tomy, sepsis, hypercoagulable states (thrombophilia or myelodysplastic syndrome), or 
contraceptive therapy (oral contraceptive use has been shown to increase the risk of 
thrombosis) 
3
. 
Case Report 
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SUMMARY 
Superior mesenteric vein thrombosis (SMVT) is a rare condition, usually caused by infec-
tions, intra-abdominal inflammatory diseases, portal hypertension, hypercoagulable 
states, or contraceptive therapy. Due to its vague symptomatology, SMVT is often diag-
nosed only after an abdominal contrast-enhanced computed tomography (CT) scan. In 
this article, we present a case of SMVT in a patient with a history of contraceptive drug 
use and a recent cytomegalovirus infection.  
A 36-year-old female was admitted to our department with the clinical symptoms of an 
acute appendicitis. The patient was a smoker and had been using hormonal contracep-
tives for over a year. Surgery was deemed the best course of action. Before the operation, 
blood tests showed a mild lymphocytosis and altered liver enzyme levels, while coagula-
tion values were normal. A contrast-enhanced CT scan revealed a complete superior mes-
enteric vein thrombosis without signs of bowel ischemia. Anticoagulants were immedi-
ately administered. A thrombophilia panel did not highlight any noteworthy elements. 
Cytomegalovirus (CMV) tests resulted positive. 
Since CMV is a rare, but potentially significant cause or precipitating factor for thrombo-
sis in immunocompetent hosts, all patients with an unexplained fever and seemingly 
spontaneous thrombosis should be screened for CMV infection. 
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SMVT often presents with nonspecific 
symptoms such as nausea, vomiting and 
abdominal pain, sometimes mimicking an 
acute abdomen 
4
. The vague symptoms 
and lack of distinct findings on physical 
examination (the abdomen is usually non-
tender on palpation), despite the severe 
pain, make the disease difficult to diag-
nose 
2
; conclusive diagnosis is generally 
delayed, and it can even be an incidental 
finding during an abdominal computerized 
tomography (CT) or ultrasound (US) scan. 
Furthermore, like in the present case, ab-
dominal US does not always detect any of 
the abnormalities caused by SMVT, and in 
such cases, contrast-enhanced CT scan 
seems to be the most sensitive investiga-
tion method. 
This article describes the case of a patient 
suffering from SMVT with a history of hor-
monal contraceptive use and a recent cy-
tomegalovirus (CMV) infection. 
 
Case report 
A 36-year-old Caucasian woman was admit-
ted to our department with a one week 
history of postprandial abdominal pain, 
located around the area of the right iliac 
fossa and responsive to paracetamol, and a 
one month history of evening rise low-
grade fever (37-38°C) with chills, malaise 
and weakness, that had been treated at 
home with intramuscular 500 mg injec-
tions of ciprofloxacin for 6 days. The pa-
tient described her pain as a dull ache, 
turning crampy in the immediate postpran-
dial period. The patient was diagnosed 
with Darier’s disease in 1999, and had 
undergone a laparoscopic cholecystectomy 
five years prior to the present admission. 
Furthermore, the patient referred a history 
of jugular vein thrombosis in her immedi-
ate family (mother), in addition to a case of 
spontaneous miscarriage and a twin preg-
nancy with threatened abortion. Medication 
history included the use of transdermal 
contraceptives (norelgestromin/ethinyl 
estradiol 6mg/600mcg) for about one year, 
followed by oral contraceptives 
(drospirenone/ethinyl estradiol 
3mg/0.03mg) for five months prior to 
being interrupted during the present hos-
pital admission. The patient had been 
smoking 15-20 cigarettes per day for the 
past 18 years. At physical examination, the 
patient presented a distended but non-
tender abdomen, although deep palpation 
in the proximity of the right iliac fossa 
resulted in minor pain. McBurney’s sign 
resulted positive and Blumberg sign weakly 
positive. Blood tests showed elevated 
gamma-glutamyl transferase (103 IU/L) 
and alcaline phosphatase (107 IU/L) serum 
levels. Aspartate transaminase (AST) levels 
were 47 IU/L, while those of alanine transa-
minase (ALT) were 45 IU/L. Coagulation 
parameters fell within normal values (INR: 
0.87) and no leukocytosis was observed 
(7030 cells/μL), while only a mild degree of 
relative lymphocytosis was detected 
(50.4%). Suspecting an appendicitis, but 
with the clinical picture still remaining 
unclear, we decided to perform an abdomi-
nal US and contrast-enhanced CT scan 
immediately preceding the intervention. 
The US scan did not evidence any abnor-
malities, whereas the contrast-enhanced 
CT scan revealed a complete superior mes-
enteric vein thrombosis without discernible 
signs of bowel ischemia (Figure 1). Further-
more, the CT scan showed a small intramu-
ral uterine leiomyoma with a diameter of 
three centimeters. Anticoagulation therapy 
was immediately commenced, administer-
ing 4000 IU of enoxaparin sodium twice 
per day. The hematologist prescribed an 
additional anticoagulant therapy of war-
farin (5 mg per day) in order to maintain 
an INR of 2.5. Paroxysmal nocturnal 
haemoglobinuria clone, Jak-2, Factor V 
Leiden (R506Q), and Prothrombin 
(G20210A) mutations resulted negative, 
while the patient presented a mutation in 
one of the two alleles of methylenetetrahy-
drofolate reductase (MTHFR) gene, and a 
4G/5G polymorphism was detected in the 
PAI-1 gene. Due to the fever, and consider-
ing past experiences recorded in literature, 
an enzyme-linked immunosorbent sero-
logic assay (ELISA) for CMV was performed. 
CMV IgM levels resulted 3.1 times higher 
than normal; CMV IgG levels were 147.0 
AU/ml. Crucially, the patient had under-
gone routine blood exams during her preg-
nancy one year earlier, and tested negative 
for CMV.  
Six months after admission, the patient 
was found to be in good health and free of 
any residual symptoms.  
 
Discussion 
SMVT can be a severe condition that could 
lead to irreversible intestinal necrosis if not 
promptly identified and properly treated. It 
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may be caused by local factors, such as 
trauma, infection, or venous obstruction, 
or be associated with hypercoagulable 
states, such as polycythemia rubra vera 
and carcinomatosis. SMVT is insidious and 
difficult to diagnose, since it often pre-
sents with nonspecific symptoms, such as 
nausea, diarrhea, vomiting, abdominal 
pain, or, as in our case, the physical signs 
of an acute abdomen caused by appendici-
tis. Treatment should be initiated while the 
patient is still in the reversible ischemia 
phase, before irreversible necrosis occurs. 
In the latter situation, an extensive surgi-
cal resection of the necrotic intestinal 
loops is required. The mortality rate for 
this condition ranges from 20% to 50% 
5
. 
Survival depends on several factors, mostly 
on the timing of diagnosis and surgical 
intervention. Short bowel syndrome is a 
major complication of SMVT surgery, sub-
ject to the extent of resection necessary 
5
. 
There are currently no reported laboratory 
findings specific for the diagnosis of SMVT; 
however, increased plasma lactate levels 
and metabolic acidosis may help to identify 
an irreversible bowel infarction, but this is 
usually a late-stage finding, and as such 
not useful for early diagnosis 
5
. Contrast-
enhanced CT scan is the diagnostic 
method of choice for suspected cases of 
mesenteric venous thrombosis. Unfortu-
nately, this technique is not as sensitive for 
thrombosis of the smaller mesenteric ves-
sels: in these patients, a mesenteric an-
giography should be performed 
5
. 
Hormonal oral contraceptive (OC) therapy 
has been available since the 1960s. To 
date, it is estimated that more than 
100,000 women use this contraceptive 
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Figure 1. Contrast-enhanced CT scan. Complete thrombosis of the superior mesen-
teric vein and its distal branches, associated with hyperdense congestive perivascu-
lar fat deposition. 
method. In the beginning of the 1970s, 
many studies showed an increased risk of 
thromboembolic and cardiovascular dis-
eases among the users of oral contracep-
tives 
6-12
. The risk has since been shown to 
be further increased in women who smoke 
or have a family history of deep vein 
thrombosis, like in the present case. It has 
been demonstrated that estrogens in-
crease the hepatic production of factors VII 
and X, and fibrinogen 
13
. Moreover, they 
decrease the levels of antithrombin III and 
protein S. In the fibrinolytic cascade, they 
increase the levels of plasminogen and 
tissue plasminogen activator (t-PA), and 
lead to a reduction in plasminogen activa-
tor inhibitor-1 (PAI-1) levels 
4
. Estrogens 
also determine an increase in platelet 
levels 
14-16
, induce intimal hyperplasia
17
 and 
are responsible for changes in lipid pro-
files. The risk of a thromboembolic compli-
cation declines within one month of dis-
continuing oral contraceptives. In the re-
ported case, no coagulation alterations or 
particularly significant gene mutations 
were registered; however, the patient’s 
medical history included a case deep vein 
thrombosis in the immediate family, and a 
previous miscarriage for unknown causes. 
Furthermore, she was a heavy smoker. All 
these elements point towards a diagnosis 
of OC-related SMVT. Interestingly, in this 
case, an intermittent fever that had lasted 
for a month, and hepatic serum enzyme 
anomalies were also present. In immuno-
competent hosts, primary CMV infections, 
when carefully evaluated at the clinical 
level, are mostly associated with mild 
clinical symptoms, such as headache, 
fatigue, fever, or sore throat 
18
. Symptoms, 
when perceptible, develop 9-60 days after 
the primary infection. CMV can cause a 
wide range of infections in immunocompe-
tent hosts. Most commonly affected sites 
include the lung (severe community-
acquired viral pneumonia), liver 
(transaminasemia), spleen (splenomegaly), 
gastrointestinal tract (colitis), central nerv-
ous system (encephalitis), hematologic 
system (cytopenias), and multisystemic 
infection (fever of unknown origin) 
19
.  A 
possible role for CMV in adrenal gland 
tumorigenesis has also been postulated 
20
. 
In the present case, the previous miscar-
riage and/or the threatened abortion could 
have been caused by the presence of the 
intramural fibroid, which are thought to be 
one of the main causes of subfertility 
21
. 
 CMV may also result in atypical lympho-
cytes in the blood. Other typical findings 
include negative heterophile antibody 
tests, mildly or moderately elevated levels 
of aspartate transaminase, and evidence of 
subclinical hemolysis 
22
. Hepatitis and 
atypical lymphocytes usually resolve within 
six weeks. CMV-associated thrombosis has 
been extensively reported in medical litera-
ture, mainly in immunocompromised pa-
tients 
23-26
.  A meta-analysis showed that 
deep venous thrombosis/pulmonary embo-
lism (DVT/PE), splanchnic vein thrombosis 
and splenic infarction were the most preva-
lent types of thrombosis associated with 
acute CMV infection 
24
. Cytomegalovirus-
related superior mesenteric vein thrombo-
sis is extremely rare, especially in immuno-
competent patients 
1,27-30
. In the few previ-
ously reported cases, all patients pre-
sented with a high body temperature, mild 
abdominal pain, altered liver enzyme lev-
els, mild lymphocytosis and a negative 
thrombophilia panel. The exact pathologic 
mechanisms through which CMV triggers 
thrombosis are still unclear. Several theo-
ries have been proposed, such as inhibi-
tion of p53-mediated apoptosis, and plate-
let-derived growth factor β-receptor escala-
tion 
31
. It has also been suggested that the 
procoagulant effect of CMV may arise from 
the infection of endothelial cells 
32
. As a 
result of either one or a combination of 
these mechanisms, CMV infection can 
induce vascular changes that may trigger a 
cascade of events that lead to inflamma-
tion and thrombosis 
33
. Regardless of the 
exact causative mechanism, there is grow-
ing evidence that CMV may induce poten-
tially life-threatening vascular damage with 
associated thrombosis. 
 
Conclusions 
Mesenteric venous thrombosis is a major 
cause of intestinal ischemia and necrosis. 
Its diagnosis is often significantly delayed 
due to the generally vague clinical presen-
tation of this condition, frequently causing 
it to be mistaken for other diseases 
(appendicitis, Crohn’s disease, salpingitis, 
peritonitis etc.); modern imaging tech-
niques enable an early diagnosis, thus 
avoiding the need for surgery. Prompt 
treatment with anticoagulants drastically 
improve the quality of life and the survival 
rate of patients. Surgical resection of the 
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bowel loops should only be resorted to in 
patients with irreversible necrosis follow-
ing a delayed diagnosis or anticoagulant 
therapy failure. Since CMV is a rare, but 
potentially significant cause or precipitat-
ing factor for thrombosis in immunocom-
petent hosts, all patients with an unex-
plained fever and spontaneous thrombosis 
should be screened for CMV infection.  
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